Literature DB >> 11257384

Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines.

G Dietrich1, A Kolb-Mäurer, S Spreng, M Schartl, W Goebel, I Gentschev.   

Abstract

Vaccination by intradermal or intramuscular injection of eukaryotic antigen expression vectors (so-called DNA vaccines) elicits strong cellular and humoral immune responses. A novel approach employs attenuated mutant strains of Gram-positive and Gram-negative intracellular bacteria as carriers for the delivery of DNA vaccines. This strategy allows the administration of the DNA vaccines via mucosal surfaces and a direct delivery of the plasmid DNA to professional antigen presenting cells (APC), such as macrophages and dendritic cells (DC). In this work, we have found that several Gram-negative bacteria are capable of delivering plasmid vectors to human DC. In addition, we tested the suitability of the Gram-positive bacterium Listeria monocytogenes as a vaccine carrier for the immunization of fish.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257384     DOI: 10.1016/s0264-410x(00)00480-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells.

Authors:  Alexandra Unkmeir; Ulrike Kämmerer; Anne Stade; Claudia Hübner; Sabine Haller; Annette Kolb-Mäurer; Matthias Frosch; Guido Dietrich
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

2.  Construction of an oral recombinant DNA vaccine from H pylori neutrophil activating protein and its immunogenicity.

Authors:  Bo Sun; Zhao-Shen Li; Zhen-Xing Tu; Guo-Ming Xu; Yi-Qi Du
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

3.  Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen.

Authors:  Ayman Al-Mariri; Anne Tibor; Pascal Lestrate; Pascal Mertens; Xavier De Bolle; Jean-Jacques Letesson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

Review 4.  Delivery technologies for human vaccines.

Authors:  Philippe Moingeon; Charles de Taisne; Jeffrey Almond
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

5.  Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.

Authors:  Aline F Oliveira; Luciana P Ruas; Silvia A Cardoso; Sandro G Soares; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

6.  Intragastric administration of attenuated Salmonella typhimurium harbouring transmissible gastroenteritis virus (TGEV) DNA vaccine induced specific antibody production.

Authors:  Heng Yang; Sanjie Cao; Xiaobo Huang; Jiawen Liu; Ying Tang; Xintian Wen
Journal:  Vaccine       Date:  2009-06-30       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.